Developing Therapeutics for Benign Hematologic Diseases скачать в хорошем качестве

Developing Therapeutics for Benign Hematologic Diseases

Hanny Al-Samkari, MD, is a classical hematologist and clinical investigator at the Center for Hematology at the Mass General Cancer Center. He conducts hemostasis research on the use of systemic therapies to treat hereditary hemorrhagic telangiectasia. His research is also exploring the development of therapeutics for a number of benign hematologic diseases. Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital. Subscribe: https://pages.connect.massgeneral.org...